Clinical Trials Logo

Clinical Trial Summary

The goal of the proposed project is to determine the effectiveness of a brief motivational intervention among Emergency Department (ED) patients who use cocaine and/or heroin to prevent Sexually Transmitted Infections (STIs) and Human Immunodeficiency Virus (HIV) by comparing cumulative incidence and frequency of safe sex behavior between intervention and standard voluntary counseling, testing and referral to substance abuse treatment (control) groups over a one year follow-up period.


Clinical Trial Description

Barriers to health care utilization limit drug users' interaction with the primary health care system, resulting in episodic health care received through Emergency Departments (ED) and Urgent Care Centers (UCC). Since 1994, the Boston Medical Center ED and UCC have provided substance abuse screening as standard of care. This program employs the Brief Negotiated Interview (BNI) to assess patient's reasons for drug use, readiness to change and offer intervention alternatives and referrals to substance treatment and other resources. Drug users' high rates of STIs, HIV, and Hepatitis C (HCV) and utilization of EDs and UCCs as usual sources of health care support the introduction of sexual behavior intervention in the ED and UCC setting. The proposed study will apply existing Brief Negotiation Interview (BNI) theory and research to a new behavioral context. The proposed project is a collaborative effort to adapt the BNI to encourage safe sex behaviors to prevent gonorrhea, chlamydia, and HIV among male and female ED and UCC patients age 18-54 years who use heroin and/or crack/cocaine and are not in treatment. We will enroll and 1:1 randomize 1,030 patients to intervention (safe sex BNI) or control (voluntary counseling and testing and referral to substance abuse treatment) over a 2.5-year period, with 6-month and 12-month follow-up. STIs and HIV will be diagnosed by specific laboratory assay at baseline, 6-month, and 12-month follow-up. Sexual and drug using behavior will be determined by participant self-report at baseline, 6-month, and 12-month follow-up on a 30 day time-line follow-up calender, with biochemical testing of hair samples for opiates and cocaine at enrollment and 12-month follow-up. Sexual behavior risk will be measured in terms of proportion of vaginal and anal sex acts protected by condom use and condom use at last sexual act, by sexual partner type. Differences in safe sex behavior between intervention and control groups will be evaluated using General Estimating Equation (GEE) modeling. After assessing intervention effect in the base model, we will assess intervention effect controlling for age, gender, race, injection use, HIV status and sexual and drug using behavior. An effective, brief intervention for safe sex behaviors to reduce STDs and HIV among drug users in ED and UCC settings may provide a sustainable intervention opportunity for drug users who are otherwise difficult to access. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01379599
Study type Interventional
Source Boston Medical Center
Contact
Status Completed
Phase Phase 3
Start date November 2004
Completion date May 2009

See also
  Status Clinical Trial Phase
Terminated NCT03098394 - Use of a Rapid Test for Gonorrhea & Chlamydia for Women Presenting With Possible Sexually Transmitted Infections N/A
Completed NCT03186183 - GPS: Adaptation Trial of an HIV Prevention Counselling Program for HIV-positive and HIV-negative Gay and Bisexual Men N/A
Completed NCT05504954 - A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women: IMARA SA N/A
Completed NCT01387646 - Behavioral Intervention for Minority Adolescent Women Phase 2
Terminated NCT00170534 - Intervention for Male STDs in India N/A
Recruiting NCT04585165 - User-friendly HIV Testing and Counseling Services
Completed NCT04021953 - The People Like Us Evaluation Study N/A
Completed NCT02993185 - Making Healthy Decisions: A Trial Evaluating the "Your Move" Teen Pregnancy-prevention Intervention N/A
Active, not recruiting NCT01088542 - The Community Youth Development Study: A Test of Communities That Care N/A
Recruiting NCT05244967 - Epidemiology of Sexually Transmitted Infections and Its iMpAcT on fEmale Infertility
Recruiting NCT05766904 - Efficacy Trial on Meningococcal B Vaccine for Preventing Gonorrhea Infections Phase 3
Completed NCT00170430 - Reducing Vaginal Infections in Women Phase 3
Completed NCT03431168 - A Novel Regimen to Prevent Malaria and STI in Pregnant Women With HIV Phase 2
Recruiting NCT04446611 - Clinical Study of STI Screening to Prevent Adverse Birth and New-born Outcomes N/A
Completed NCT02868346 - Improving the Diagnosis of Sexually Transmitted Infections in Emergency Rooms N/A
Completed NCT02740998 - Long-Acting Progestin Contraception and the Vaginal Microbiome
Completed NCT04207151 - Expanding PrEP By Embedding Unannounced SNAPS Navigators in High STI Testing Clinical Sites N/A
Completed NCT02498067 - rPlan Multimedia Dual Protection Intervention to Reduce Health Disparities N/A
Active, not recruiting NCT05541081 - Investigating Point-of-care Diagnostics for Sexually Transmitted Infections and Antimicrobial Resistance in Primary Care in Zimbabwe N/A
Active, not recruiting NCT05708014 - Personalized Prevention for Couples: A 16-month Digital RCT N/A